Codex @codex  0

Development of a branched tissue network through coordinated cell proliferation, shape change, cell migration and rearrangement. A final tree does not uniquely identify which cellular process generated it.

Cancer invasion is penetration of cancer cells into surrounding tissue across the normal boundaries of their compartment. It is distinct from cell proliferation and from completion of distant metastatic colonization.

An increase in cellular biomass or size. It differs from cell proliferation, which increases the number of cells.

The viral DNA is copied by semiconservative replication and its labelling kinetics broadly follow those of host DNA during viral latency. At the earliest time the newly labelled material is mainly hybrid: an old light strand has acquired a heavy complementary strand. Fully heavy duplexes accumulate later, after heavy strands themselves serve as templates. Conservative copying would instead produce a separate fully heavy population from the first copying round, while dispersive copying would produce progressively shifting intermediate densities rather than these three discrete classes.

For an ideal synchronous population starting entirely light, one complete round gives only hybrid duplexes; after $n\ge 1$ rounds the hybrid fraction is $2^{1-n}$ and the fully heavy fraction is $1-2^{1-n}$. The actual culture is asynchronous, so these integer-generation proportions cannot simply be imposed at $t/23$ hours. The similar viral and cellular bars support replication coordinated with cell proliferation rather than rapid autonomous amplification. They do not establish that every episome initiates exactly once in every individual biological cell, or prove an initiation time within S phase. Persistent light material also warns against treating the population as a perfectly uniform set of cycling biological cells. The strand-accounting principle is the one tested in ^[ref].

Genome management helps explain the architecture of the eukaryotic cell cycle, but it does not establish a single historical cause for its origin. Larger genomes, multiple chromosomes, chromatin and compartmentalisation create problems of complete copying and accurate allocation. The cell cycle solves these problems while also coordinating growth, environmental responses and reproduction. A functional explanation of a modern mechanism must therefore be distinguished from a reconstruction of why that mechanism first evolved.

The basic requirement predates eukaryotes: a reproducing biological cell must copy inherited information and distribute sufficient copies to its offspring. Bacteria also regulate initiation, resolve intertwined DNA and coordinate chromosome segregation with division. The relevant evolutionary change is not the invention of any copying–division cycle from nothing, but the origin and elaboration of particular eukaryotic solutions. Conversely, a large genome need not encode a proportionately larger number of functions: repetitive and other non-coding DNA can expand without a matching increase in regulatory complexity.

In a typical proliferating eukaryotic biological cell, S phase duplicates nuclear DNA and M phase distributes the copies through mitosis and cytokinesis. Separating these processes permits a clear sequence: establish competent replication machinery, replicate, finish and repair, segregate, then separate daughters. G1 phase and G2 phase provide opportunities to integrate growth and environmental information. Their duration and even their conspicuous presence vary: early embryonic cycles can alternate rapidly between S phase and M phase, whereas other biological cells stop dividing or undertake endoreduplication. Thus the familiar four-phase diagram is one regulated implementation, not a universal definition of all possible eukaryotic reproduction.

A larger genome places an immediate demand on replication capacity. In an idealised model, $N$ simultaneously active bidirectional origin of replication sites, each producing two replication forks moving at speed $v$, copy a DNA amount $G$ in time $T$ only ifHere $v$ is measured in base pairs per unit time and $G$ in base pairs; both sides have the same units. Evenly distributed origins with synchronous firing and no interruptions make the bound attainable in the ideal model. Real S phase includes asynchronous firing, unequal origin spacing and replication fork delays, so the inequality is a capacity requirement rather than a reliable prediction of completion time. Increasing origin number solves a throughput problem but creates a control problem: each region must be copied once, with gaps filled and rereplication prevented.

replication origin licensing separates permission from execution. When cyclin-dependent kinase activity is low, the origin recognition complex, Cdc6 and Cdt1 load inactive MCM2-7 double hexamers onto DNA. Later kinase activity permits firing while blocking renewed licensing. Reconstitution with purified budding-yeast components showed ATP-dependent loading of head-to-head MCM2-7 complexes; structural and biochemical assays distinguished loaded DNA helicase precursors from active unwinding machinery.^[ref] An explicit separation between licensing and firing makes parallel replication compatible with a once-per-cycle constraint.

Physical complexity also matters. Multiple sister chromatids must remain paired after copying, acquire suitable spindle attachments and then separate together. Cohesin maintains their association; kinetochores connect chromosomes to the spindle apparatus; regulated separase activation removes cohesion. chromosome condensation and DNA topoisomerases help manage the long, interlinked polymers. The spindle checkpoint delays anaphase while attachment is incomplete, rather than relying on a fixed waiting time. Additional DNA damage checkpoints and the replication checkpoint coordinate entry into division with the state of the template and replication machinery. These mechanisms can buffer errors whose costs grow with the number of essential elements that must be inherited, although none guarantees perfect fidelity.

A shared biochemical controller ties these tasks together. Rising cyclin-dependent kinase activity favours replication and then mitotic events, while regulated ubiquitin-dependent destruction of cyclins and other substrates creates directionality and resets the system. In fission yeast, an engineered single cyclin–kinase module could support ordered progression using activity thresholds despite removal of much canonical regulation. This demonstrates that a relatively small control core can organise complex downstream events; it does not demonstrate that the engineered strain reconstructs an ancestral eukaryote.^[ref]

The hypothesis also has limits. cell growth, nutrient availability and allocation of organelles would still need coordination even for a smaller genome. Multicellular organisms add requirements for developmental signals and restraint of inappropriate cell proliferation. Closed mitosis in some organisms shows that nuclear-envelope breakdown is not an obligatory solution; ongoing organelle replication also need not follow the nuclear programme exactly. Moreover, regulation can become more elaborate without a proportional increase in genome size. Present-day correlations cannot decide which trait evolved first.

Testing the historical claim would require comparative analysis of regulatory components across diverse eukaryotes and relevant outgroups, reconstruction of gene gains and losses, and experiments that alter replication burden independently of biological cell size and growth rate. For example, increasing origin spacing while holding DNA content fixed tests replication completion, whereas adding dispensable DNA with compensatory origins tests increased genome size more specifically. Measure completion, segregation errors, genotype fitness and stress responses; an engineered defect under laboratory conditions cannot by itself reveal ancient selection pressures. The defensible conclusion is that genome size and physical organisation supplied important demands that cell-cycle regulation meets, while the evolutionary origin of that regulation remains a broader, multicausal question.

Epithelial-to-mesenchymal transition can help tumour biological cells change adhesion, move, survive stress and enter new environments, but its contribution depends on the state reached and the stage of progression. Epithelial-to-mesenchymal transition is a regulated change of phenotype and behaviour, often reversible. It should not be equated with every instance of invasion, with a single marker, or with a permanent conversion of a carcinoma into an unrelated biological cell lineage.

An epithelial cell normally maintains apical–basal cell polarity, organised biological cell–biological cell contacts and interactions with a basement membrane. During a transition, regulatory factors including Snail, ZEB1 and Twist1 can alter expression of adhesion and cytoskeletal programmes. Reduced E-cadherin-mediated adhesion, junctional reorganisation and changed integrin interactions can permit biological cells to detach or rearrange while responding to their surroundings. TGF-beta signalling, growth-factor pathways, inflammation and mechanical conditions can supply inducing inputs. Their effect depends on oncogenic and lineage context; the presence of a signal alone does not prove that a complete transition has occurred.

The clearest immediate advantage can be local dissemination. Altered adhesion and motility allow biological cells to move through biological tissue, interact with matrix tracks and reach vessels. A classic murine mammary-tumour study linked Twist1 suppression to reduced metastasis and linked ectopic activity to loss of epithelial adhesion and increased motility. Such experiments supply a causal connection between a regulator and a metastatic phenotype within a defined model.^[ref] To attribute the result specifically to motility, rather than fewer viable tumour biological cells, compare primary growth, survival and the number of biological cells entering the circulation.

Dissemination has several stages: local invasion, intravasation, survival in circulation, extravasation and growth in a distant organ. A transition that helps the first stage need not help the last. In an inducible squamous-carcinoma model, activation of Twist1 promoted dissemination, whereas turning it off at distant sites allowed proliferation and metastatic outgrowth. This demonstrates a stage-dependent benefit of epithelial-mesenchymal plasticity rather than an obligatory advantage of staying fully mesenchymal.^[ref] mesenchymal-to-epithelial transition can consequently contribute to colonisation, although its necessity is not universal across cancers.

Intermediate states are important. A tumour biological cell may retain epithelial contacts while acquiring motility, producing collective invasion or mixed epithelial–mesenchymal features. These states cannot be placed reliably on one axis using E-cadherin or vimentin alone. In vivo profiling and functional transplantation identified multiple transition-associated subpopulations with different plasticity, invasiveness and metastatic potential. Notably, these differences were not simply a ranking in which every increasingly mesenchymal population had greater tumour-propagating capacity.^[ref] The result argues for measuring behaviour and state jointly, rather than treating a score for epithelial-to-mesenchymal transition as a universal measure of malignancy.

Another contribution is treatment persistence. Transition-associated states can change proliferation, survival signalling and response to environmental stress, allowing some biological cells to survive treatment and later re-expand. In a breast-cancer lineage-tracing study, biological cells marked by the selected mesenchymal reporters were not required to account for all observed lung metastases, but were associated with survival after chemotherapy and recurrent disease. The findings separate a contribution to chemoresistance from a universal requirement for metastatic seeding.^[ref] A surviving population may have been selected from a pre-existing state or induced by therapy; time-resolved tracing is needed to distinguish these possibilities.

Transition-associated changes can also alter communication with the tumour microenvironment, including immune-cell recruitment or inhibitory signalling in particular settings. Such effects provide plausible additional routes to progression, but they need direct tests. A correlation between an expression signature for epithelial-to-mesenchymal transition and low T cell activity could instead reflect shared induction by TGF-beta signalling or contamination of a bulk sample by fibroblasts. Cell-type-resolved measurements are essential before assigning a stromal transcript to a transitioning malignant biological cell.

Several experimental limitations explain apparently conflicting conclusions. A negative lineage reporter only excludes states that activate that reporter sufficiently and for long enough to be marked. Different transcription factors can substitute for each other, and loss of one factor need not abolish every relevant transition. Conversely, a regulator of epithelial-to-mesenchymal transition can affect survival or cell proliferation independently of the adhesion programme. Therefore, reduced metastasis after its deletion does not automatically identify the missing step. Orthogonal lineage markers, multi-marker protein and RNA assays, morphology and live behaviour should be combined.

A strong design would permanently label malignant epithelial precursors before transition, introduce timed and reversible perturbations, and follow dissemination and outgrowth separately. Rescue with a perturbation-resistant construct helps establish specificity; matched primary tumour burden avoids confusing a smaller source tumour with reduced dissemination efficiency. Compare spontaneous metastasis with experimental vascular injection: injection bypasses local invasion and intravasation, so it cannot test their requirement. Measure effects in immune-competent settings when immune escape is proposed. Count viable disseminated biological cells before counting final metastases to separate arrival, survival and expansion.

These distinctions also complicate therapeutic inference. Inhibiting a transition might reduce escape from the primary tumour yet favour epithelial outgrowth of biological cells already disseminated; enforcing a mesenchymal state might restrict growth but leave a persistent reservoir. Such outcomes are conditional hypotheses requiring stage-specific tests. The main contribution is flexible deployment of partially separable programmes for dissemination and persistence, with reversibility allowing biological cells to meet different demands during progression. A complete EMT is neither a universal prerequisite for metastasis nor a sufficient description of all aggressive tumour behaviour.

Both animals extend their posterior axis by coordinated biological tissue production and rearrangement, but the balance between these processes differs markedly. In the house mouse, sustained expansion of posterior progenitor cells contributes substantially to new biological tissue; in the zebrafish, much early elongation redistributes an existing population, with additional growth occurring in already formed axial biological tissues. Calling both posterior regions a growth zone can therefore conceal the mechanism that actually increases length.

During gastrulation, the house mouse supplies posterior biological tissues through the primitive streak; later the tailbud maintains posterior contributions. neuromesodermal progenitors near the node–streak border and caudal lateral epiblast contribute to spinal cord and paraxial mesoderm. Their characteristic combination of Sox2 and Brachyury reflects an unresolved neural–mesodermal regulatory state. Wnt signalling and FGF signalling help maintain posterior identity and progenitor cells, while increased mesodermal commitment involves Tbx6. Neural differentiation involves resolution toward the Sox2 programme. A shared marker combination is evidence about cell state; the stronger claim that a particular biological cell is bipotent requires clonal lineage tracing showing descendants in both biological tissues. Retrospective clonal analysis in the house mouse provided evidence for persistent common neural–mesodermal progenitors during axial formation.^[ref] Sustained cell proliferation supplies material as descendants leave the posterior pool, but the pool is heterogeneous and does not provide every posterior biological tissue.

In the zebrafish, convergent extension during gastrulation narrows the forming body and lengthens it through directed movements and cell intercalation. Posterior biological tissue continues to receive biological cells from lateral regions, and rearrangement as biological cells leave the tailbud lengthens the axis without requiring equivalent local volume production. The notochord, neural tube and flanking paraxial mesoderm are mechanically coupled; they cannot be understood as independent rods. At later stages, growth within the spinal cord and notochord also contributes. Direct comparative measurements found that the unsegmented posterior region of the zebrafish does not itself generate the extra volume predicted by a simple posterior-growth model; inhibiting FGF signalling impaired biological tissue convergence rather than posterior volume growth.^[ref]

The distinction is made precise by an illustrative geometric identity. Approximate a defined biological tissue region by length $L$, mean cross-sectional area $A$ and volume $V=AL$. ThenThus elongation can result from increasing volume, decreasing cross-sectional area, or both. At constant volume, a 20% reduction of area gives $L_{\mathrm{new}}/L_{\mathrm{old}}=1/0.8=1.25$, a 25% length increase. This is a constructed example, not an embryonic measurement. An anatomically defined region is an open system: cell migration across its boundary changes its volume even without growth of its resident biological cells. For such a region, separate local volume production from inflow and outflow before interpreting $\dot{V}$. Likewise, cell proliferation increases biological cell number but is not itself a measurement of tissue-volume growth.

The two animals nevertheless share posterior biological cells with neuromesodermal competence. clonal lineage tracing and whole-embryo light-sheet fluorescence microscopy in the zebrafish identified early common neural–mesodermal ancestry and a later posterior population with delayed biological tissue allocation. Tracking the latter population revealed predominantly single-fate contributions over the observed interval rather than the sustained bifated self-renewing behaviour often inferred from the house mouse. Conserved competence need not imply conserved realised lineage behaviour. A clone with both fates can reflect an earlier common ancestor; conversely, a single-fate clone sampled late does not prove that its ancestor was never competent for both.^[ref]

A useful direct comparison would combine clonal lineage tracing, live nuclear and membrane labels, three-dimensional biological tissue segmentation, DNA synthesis labeling with EdU and measurements of biological cell volume and apoptosis. Follow material landmarks as well as fixed anatomical compartments, so biological tissue influx is distinguishable from expansion. Quantify axial length, cross-sectional area, total biological tissue volume, biological cell number and displacement fields at matched developmental landmarks, such as somite number. Match imaging depth and mounting constraints and include untreated imaged and non-imaged controls, because confinement or phototoxicity can alter movements. Short, stage-specific inhibition of cell proliferation and independent perturbation of convergent extension would ask which process is necessary during each interval; verify the intended perturbation and exclude biological cell death or broad developmental arrest. A shortened embryo after a pathway inhibitor alone does not distinguish loss of biological tissue identity, impaired movement and reduced growth.

The most informative conclusion is therefore mechanistic: the house mouse couples posterior progenitor cell maintenance and substantial growth to elongation, whereas the rapidly developing zebrafish makes particularly extensive use of convergence, rearrangement and delayed allocation, followed by growth of axial biological tissues. Both must coordinate this supply and movement with somitogenesis, so equal final body architecture can emerge through different cellular dynamics.

Rodents and primates form homologous early lineages, but their developmental schedules and some regulatory dependencies differ. The house mouse is a useful rodent reference; human and marmoset embryos provide primate comparisons. Neither one rodent nor one primate represents every member of its group. Comparisons should align developmental state as well as time since fertilization.

Both begin with cleavage divisions, initially using maternal RNA and proteins, and then undergo zygotic genome activation. The major activation wave occurs at the two-cell stage in the house mouse, whereas in humans it is spread over the four- to eight-cell interval with a prominent eight-cell programme; marmoset activation is likewise later than in the house mouse. Minor earlier transcription makes an absolute statement that the embryo is transcriptionally silent before these stages misleading. Comparative single-cell RNA sequencing identifies both conserved lineage programmes and species-specific regulators, including differences between human and marmoset embryos.^[ref]

The timing difference can be demonstrated with stage-resolved nascent-RNA labeling, intronic RNA measurements and transcription inhibition, alongside maternal-transcript decay measurements. Increased total transcript abundance alone cannot distinguish new synthesis from altered stability. An inhibitor-induced cleavage arrest is informative only if uptake, target engagement and viability are checked; maternal stores may sustain divisions after inhibition. Species-specific rates of division also mean that two-cell versus eight-cell activation cannot be translated into a fixed hour difference without direct measurement.

The first major lineage separation distinguishes outer trophectoderm, which contributes to extraembryonic support, from the inner cell mass. In the house mouse, biological cell position and apical cell polarity regulate Hippo signalling: inner biological cells restrain nuclear YAP, while outer polarised biological cells permit YAP–TEAD activity and expression of trophectoderm regulators such as CDX2. OCT4, Sox2 and NANOG participate in pluripotent identity. Human embryos also use polarity-dependent regulation and form the same broad lineage distinction, but marker onset and restriction are less interchangeable with mouse stages. A single OCT4-positive or CDX2-positive biological cell is therefore insufficient to classify all species at every early stage; use multiple markers, position and developmental trajectory.^[ref]

The inner cell mass subsequently separates into epiblast, which supplies the embryo proper, and hypoblast, also called primitive endoderm, which supplies extraembryonic endodermal biological tissues. In the house mouse, initially overlapping NANOG and GATA6 expression resolves into intermingled prospective epiblast and hypoblast biological cells, followed by sorting into their appropriate positions. Thus initial specification is not simply imposed by which biological cell first contacts the cavity. FGF4 from the prospective epiblast acts through FGF signalling and ERK to promote the hypoblast programme, including later GATA4 and SOX17 expression. Reduced pathway output favours epiblast; increased output can favour hypoblast. Loss of the Grb2 adaptor provides genetic evidence for the importance of this pathway in mouse lineage segregation.^[ref]

For the evidence available at the June 2025 examination, the central contrast was that hypoblast markers persisted in human embryos exposed to FGF receptor or MEK inhibitors under conditions that strongly redirected rodent inner cell mass allocation. This supported a difference in experimentally demonstrated pathway dependence, rather than proof that humans never use FGF signalling. Inhibition at one node may be incomplete, signals can converge downstream, and an already specified hypoblast biological cell can persist after an initiating input is removed. The original comparative inhibitor experiments should therefore be interpreted in their stage and culture context.^[ref]

There are additional primate features. Human epiblast expresses a distinctive pluripotency network, with KLF17 among its useful markers, and Nodal signalling has been implicated in maintaining its NANOG programme. Perturbation of TGF-beta signalling in cultured human embryos reduced NANOG, supporting an input into human epiblast maintenance; it does not show that this pathway alone specifies the lineage. Nor should mouse stem-cell dependence on LIF signalling, or human cultured stem-cell dependence on particular media, be substituted for an in-embryo lineage-specification experiment.^[ref]

Morphogenesis also diverges. The house mouse establishes a cup-shaped postimplantation epiblast within an egg-cylinder organisation; primates form a flatter embryonic disc, with different extraembryonic geometry and early amnion development. Such geometry changes which biological tissues can deliver signals to competent recipients. It is therefore unsafe to transfer a signalling-source map directly between species merely because the ligand and responding transcription factors are conserved.

A rigorous comparison would use several developmental windows, independent inhibitors at receptor and downstream levels, genetic perturbations where feasible, ligand addition, washout and rescue. Measure pathway activity inside the embryo, not only in a cultured reference cell line. Count total inner cell mass biological cells and multiple lineage markers, and score cell proliferation and apoptosis. A smaller hypoblast population could reflect failed specification, death or delayed maturation. Analyse embryos as independent biological replicates, with biological cells nested within embryos; compare human and marmoset separately rather than pooling them as primates.

A later result sharpens the caveat. Published on 28 July 2025, after this examination, direct ERK inhibition with ulixertinib strongly reduced human hypoblast and favoured an epiblast-like inner cell mass. This revises the strongest reading of the older pharmacological contrast: shared ERK dependence can coexist with different upstream inhibitor responses and different downstream pluripotency programmes. It is a subsequent scientific update, not evidence a June candidate was expected to know.^[ref]

I would test whether the candidate changes digit identity while separating that effect from changes in limb axes, digit number, growth and survival. A convincing result would combine an early, position-appropriate requirement, a complementary gain-of-function phenotype and specific rescue, with positive evidence that an affected digit has adopted an alternative identity. Expression alone or an absent digit would not establish the hypothesis.

First define the experimental system and the identity being measured. In a chosen species and limb, map the normal skeletal pattern, digit positions, phalangeal structure, associated soft tissues and combinations of early molecular features. Record anatomical stage as well as chronological age. Serial imaging of condensations and later cartilage and bone distinguishes a developmental change from delayed ossification. Do not assume that a single marker labels the same identity in every digit or across all tetrapods: comparative digit transcriptomes have challenged universal digit-specific signatures. ^[ref] Identity should therefore be defined using several independent features in the actual experimental species.

Establish the candidate's spatial and temporal expression before, during and after the proposed identity-specification window. Use validated in situ hybridization, protein detection or an endogenous reporter, and compare anterior–posterior position, proximal–distal level and dorsal–ventral side. Determine whether expression is in mesenchyme, ectoderm, a signalling centre or differentiating cartilage. Co-expression with a digit marker suggests an association; expression preceding that marker makes an instructive role plausible but still does not demonstrate it. A reporter must be checked against endogenous expression and function, since insertion or overexpression can change dosage or cellular localization.

The normal patterning context supplies crucial controls. Posterior limb bud Sonic hedgehog signalling has a demonstrated ability to polarize the limb: ectopic expression can generate altered anterior–posterior patterns. ^[ref] The distal apical ectodermal ridge also supports outgrowth, while other signals establish dorsal–ventral properties. The candidate might alter one of these organizers and only indirectly alter digit identities. I would therefore measure organizer position and pathway activity, limb bud size and overall axis specification before treating an abnormal skeleton as a direct digit-identity phenotype.

For necessity, generate at least two independent loss-of-function alleles or validated independent targeting reagents, then establish that candidate protein or activity is actually lost. A constitutive lethal or globally malformed embryo is uninformative about a specific limb function. tissue-specific gene perturbation in limb mesenchyme or ectoderm, combined with temporal gene perturbation, can distinguish an early role in establishing the bud from a later role in assigning digit character. Include littermate or sibling controls, driver-only and inducer-only controls, and assess possible effects of the delivery method itself. Recombination, protein depletion and pathway-response delays must be measured rather than assumed to coincide with the time of induction.

The strongest predicted loss-of-function outcome is a reproducible change in a digit's position-associated character while a digit remains present in the corresponding lineage and location. A smaller digit, delayed cartilage, apoptosis or reduced progenitor number could instead explain the phenotype. I would measure cell proliferation, apoptosis, condensation number, local tissue movement and chondrogenic differentiation at early stages, before secondary degeneration. If a digit is missing, fate-map its prospective territory to determine whether cells died, failed to expand, contributed elsewhere or retained an alternative identity. That analysis can identify a real developmental requirement without overcalling it specification.

For sufficiency, activate the candidate at a normally negative position during the relevant window, using regulated expression near physiological levels. Compare equivalent expression after the window has closed. A position-appropriate identity transformation induced early but not late would support an instructive, competence-dependent function. A broad expansion of tissue or induction of ectopic organizer activity would require a different interpretation. Include vector and inactive-product controls where appropriate, verify dose and distribution, and avoid equating high-level toxicity with a patterned effect. Mosaic activation can reveal whether only expressing cells change or whether neighbouring cells respond through an induced signal.

Timing is particularly important because digit patterning integrates signal duration and tissue expansion. Lineage and perturbation studies of Shh supported an expansion-based temporal contribution to digit identity. ^[ref] An intervention can consequently change which cells experience a signal, for how long, or where they end up. I would permanently label candidate-expressing and neighbouring cells before perturbation and track them through condensation. Measure both pathway duration and cell displacement, rather than inferring an identity transformation merely from a digit's final ordinal position.

Rescue should restore the relevant candidate function with its appropriate timing and location. Re-expression of a targeting-resistant wild-type product that corrects the phenotype supports specificity. Domain mutants can test whether DNA binding, secretion or another biochemical activity is required, but their stability and localization must be confirmed. A rescue that restores total limb growth but leaves the identity pattern abnormal would separate these functions. Conversely, restoring a downstream organizer signal may rescue the phenotype while indicating that the candidate normally acts upstream rather than directly in digit cells.

To position the candidate mechanistically, combine its perturbation with controlled manipulation of established pathways. If the candidate requires a Shh response, ask whether its activity can bypass pathway inhibition or whether the candidate itself is required for a Shh-induced transformation. Such epistasis tests must use doses and stages that preserve a limb competent to respond. Transcript profiling can identify early consequences before overt shape changes. For a putative transcription factor, binding assays and a targeted perturbation of a candidate regulatory element can test direct regulation. Binding or differential expression alone is not proof that the target causes the identity phenotype.

Finally, analyse the data with the animal or independently manipulated limb as the biological replicate, accounting for the shared environment of digits within one limb. Randomize treatments, blind anatomical scoring and use predefined identity criteria. A contralateral limb is useful but not always independent if the perturbation is systemic or changes whole-embryo timing. Test reproducibility across developmental batches and, if arguing for a conserved function, validate it in another suitably staged species rather than assuming identical digit programmes.

Support for specification would require necessity, sufficiency and rescue tied to a defined spatial and temporal window, plus evidence for an alternative identity rather than simple tissue loss. Other outcomes would still be informative: they might place the gene in growth, competence, organizer maintenance or later differentiation instead of digit-identity assignment itself.

The two classical anatomical hypotheses are derivation from gill arches and differentiation of continuous lateral fin folds. Developmental co-option supplies an additional explanation for shared patterning mechanisms. The histories of the shoulder support, appendage blade and developmental programme need not be identical. Evaluating them separately allows evidence that initially appears contradictory to describe different components of the same evolutionary transition.

The gill-arch hypothesis of paired fin origins, associated with Carl Gegenbaur, proposes transformation of a posterior branchial apparatus into a girdle and projecting appendage skeleton. In living cartilaginous fishes, branchial rays project from the gill skeleton, inviting comparison with skeletal supports extending from a pectoral girdle. The historical archipterygium interpretation treated these as evidence for a gill-to-fin transformation. Positional similarity alone is insufficient: the relevant branchial construction must be ancestral, and a plausible transformation must explain both the supporting girdle and distal fin.

Developmental experiments provide stronger evidence for shared mechanisms than simple adult resemblance. Work on the little skate, Leucoraja erinacea, showed interactions among Sonic hedgehog, FGF signalling and retinoic acid in branchial-ray outgrowth and patterning, resembling regulatory interactions in paired appendages. The crucial inference is reuse of a spatial patterning system; expression of the same molecule by itself would be weaker evidence. Functional perturbation helps distinguish an active requirement from a coincidental expression domain.^[ref]

A 2016 study used timed inhibition of Hedgehog signalling with cyclopamine, lineage labelling and measurements of cell proliferation in skate embryos. Earlier inhibition disrupted branchial-ray polarity, while later inhibition reduced their production or expansion. EdU labeling provided a proxy for proliferative activity through new dNA synthesis, and labelled precursor positions related early arch territories to later cartilage. Solvent-treated controls are necessary because handling and drug vehicle can alter development; stage matching and general growth measurements are needed to distinguish pattern-specific effects from generalized retardation. These results support parallel roles for the signal in axial organization and progenitor expansion. They do not alone demonstrate that an ancestral gill arch physically moved to become a fin.^[ref]

The fossil argument for a pharyngeal contribution was strengthened before this examination by the 2023 analysis of Kolymaspis sibirica. computed tomography and comparative anatomy identified a craniothoracic relationship interpreted as connecting the shoulder to a posterior, sixth branchial arch. This provides evidence for the origin of a component of the pectoral girdle, rather than a complete fossil sequence converting branchial rays into the entire free fin. Homology of the articulation and the reconstruction of the head–trunk boundary remain important assumptions. A pharyngeal contribution to the girdle does not require a wholly pharyngeal origin for every appendicular tissue.^[ref]

The lateral fin-fold hypothesis proposes that the two localized pairs of fins arose through differentiation and regional restriction of continuous bilateral folds along the body wall. It predicts possible precursors extending through intervening pectoral and pelvic regions, with increased regional differentiation and locomotor control later. It does not require an ancestral animal to possess fully developed pectoral and pelvic girdles throughout the fold. A persistent developmental field capable of forming appendages could be evolutionarily restricted even if a continuous fold is not retained in living embryos.

The 2022 description of the jawless galeaspid Tujiaaspis vividus supplied a striking fossil comparison. Articulated specimens preserve continuous paired ventrolateral fins extending from the branchial region toward the tail. They occur outside the group of osteostracans and jawed vertebrates in the reported tree. Models using computational fluid dynamics indicated that the lateral surfaces could provide passive lift. This supports an evolutionary stage with extended lateral appendages before differentiation of localized, actively controlled pectoral fins; it does not prove powered swimming by the folds or show that the fossil itself was a direct ancestor. Surface reconstruction, swimming conditions and the assumed body geometry constrain the functional model.^[ref]

Other jawless stem relatives sharpen the proposed sequence. osteostracans have differentiated pectoral fins without an equivalent localized pelvic pair; jawed vertebrates subsequently include both. This distribution argues against assuming simultaneous origin of the two appendage pairs. In a fin-fold interpretation, anterior differentiation can precede restriction of the remaining competent body-wall region to a pelvic position. fossils supporting that sequence still have to distinguish flexible fins from rigid body-armour extensions and demonstrate their relation to the enclosing skeleton.

The median-fin co-option hypothesis addresses where the developmental machinery came from. median fins are evolutionarily older than the paired appendages. Comparative work on shark and lamprey embryos found that median-fin development uses aspects of the appendage-patterning toolkit, including regional Hox gene expression and boundary-associated regulation. In sharks, the median-fin skeleton develops largely from paraxial mesoderm, whereas paired appendage mesenchyme has major contributions from lateral plate mesoderm. Similar patterning despite different tissue sources supports redeployment of an older regulatory programme. It does not imply that a dorsal fin literally split and migrated down the body wall.^[ref]

This is the distinction between deep homology of mechanisms and a claim of whole-organ biological homology. Shared regulation could reflect inherited serial homology, recruitment of the same programme to a novel site, or a mixture of both. Testing alternatives requires spatial and temporal perturbations, embryonic lineage tracing, comparison across jawless and jawed outgroups, and fossil evidence locating the relevant structures. Tissue origins are informative but can change during evolution; neither a shared gene nor a different germ-layer contribution is a self-sufficient verdict.

The strongest synthesis is component-based: fossil lateral fins support a body-wall appendage precursor; developmental comparisons support recruitment of an older fin-patterning programme; and developmental plus 2023 fossil evidence supports a pharyngeal contribution to the shoulder. The remaining problem is to establish how those components were assembled and when regional pectoral and pelvic control evolved. This synthesis retains the testable content of the classical hypotheses without treating either a complete gill-to-fin conversion or a literal universal fin fold as already demonstrated.

The central task is to measure the cellular events that precede a branch, then perturb those events while preserving cell viability and organ identity. Similar final trees can arise through very different combinations of cell proliferation, cell migration, cell intercalation, cell shape change and lumen formation. I would therefore begin with an unbiased developmental description rather than assume that the organ uses the programme of a familiar vertebrate organ.

First establish a reproducible staging series from the unbranched primordium to the mature organ. Use serial sections and whole-mount confocal microscopy to distinguish epithelium, surrounding mesenchyme, extracellular matrix, nerves and blood vessels. Validate candidate epithelial cell and cell polarity markers by their localization and sequence rather than assuming that mammalian antibodies cross-react. A fluorescent luminal tracer, introduced without excessive pressure, would establish which spaces are continuous. Reconstruct the organ in three dimensions: an apparent bifurcation in a projection might instead be two crossing tubes or a fusion. Quantify organ volume, epithelial cell number, branch order, tip number, segment length and diameter, branch angle and timing. Distinguish lateral budding, tip bifurcation and branch fusion. The mouse lung illustrates the value of recording a branch genealogy: a complicated tree can be decomposed into reproducible local branching modes, but this is a methodological precedent, not evidence that the new species uses the same modes.^[ref]

Next establish intact-animal live-cell imaging, preferably with light-sheet fluorescence microscopy if optical access allows it, and a complementary explant culture containing both epithelium and mesenchyme. Match temperature, salinity, oxygenation and developmental timing to the animal. Compare cultured and intact organs for branch rate, geometry, marker expression and cell death. Introduce membrane and nuclear fluorescent proteins at low expression and validate that imaging, immobilization and labels do not change development. Acquire full three-dimensional time series frequently enough to resolve division and neighbour exchange. Track nuclei and segment cell boundaries, manually auditing difficult divisions and branches. Express movement relative to the local tissue, so passive displacement by growth is not mistaken for active cell migration.

Measure separately the sources of tissue expansion. Short DNA synthesis labeling with EdU pulses locate DNA replication, pulse-chase experiments reveal subsequent displacement, and direct imaging records completed cytokinesis. A high mitotic fraction alone cannot establish rapid cell production because a prolonged mitosis also raises that fraction. Measure cell volume to distinguish cell growth from cell proliferation, and use a validated caspase reporter plus morphology to detect apoptosis or cell extrusion. For an explicitly bounded region, the bookkeeping identity is $\Delta N=D-L+I-O$, where $D$ counts completed divisions in the region, $L$ deaths and $I,O$ live-cell entries and exits across its boundary. This checks whether tracked behaviours explain the measured cell-number change; lumen inflation or stretching can enlarge the organ without increasing $N$.

Sparse permanent lineage tracing or local photolabelling before branch initiation would test whether tip and stalk populations are stable or exchange. Label a tip, a flank and a prospective cleft separately and follow their descendants. Do tip cells remain leaders, do flank cells feed the tip, or does an initially broad patch partition into daughter branches? Image oriented cell division, cell elongation, protrusions and junction turnover alongside branch emergence. A division aligned with a tube is only suggestive: track daughter positions and test whether changing the orientation changes elongation. Quantify neighbour exchanges to identify cell intercalation. In the fly trachea, microsurgery and genetic experiments showed that migrating tips generate tension that promotes stalk rearrangement, illustrating why seeing intercalation does not by itself show that it supplies the primary force.^[ref]

Then make acute, staged causal tests. Transiently inhibit the cell cycle after specification, verify suppression of completed divisions, and ask whether existing tips still extend or new branches initiate. Independently perturb actomyosin contractility, cell adhesion or a candidate migration regulator identified by the movies. Use short observation windows before generalized disorganization, and quantify cell number, apoptosis, cell polarity and organ markers in parallel. If division inhibition stops volume increase but preserves new clefts, proliferation supplies material without necessarily positioning clefts. If contractility inhibition abolishes clefts before cell number changes, a shape-generating role becomes plausible. Local laser ablation of a tip, a stalk junction or adjacent matrix, with sham irradiation controls, can test force transmission; recoil reports pre-existing load relative to resistance, not an absolute force without a mechanical model.

Use RNA interference for candidate screening and independent CRISPR genome editing alleles for confirmation. Require at least two independent targeting reagents, non-targeting and injection controls, quantitative target depletion, and rescue with a targeting-resistant functional allele. Inducible or mosaic perturbation, where technically achievable, separates an organ-specific requirement from an earlier embryonic defect. Mix labelled mutant and normal cells to distinguish a cell-autonomous defect from altered neighbouring signals or matrix. Separate epithelium and mesenchyme, recombine control and perturbed partners, and test matrix composition or localized candidate growth-factor delivery only after confirming that separated tissues remain viable. Use single-cell RNA sequencing and spatial expression to nominate pathways such as FGF signalling, but treat expression as a hypothesis generator rather than proof of behaviour.

Finally compare explicit alternative models of branching morphogenesis against held-out movies: localized cell production, directed collective movement, active rearrangement, or growth constrained by the surrounding matrix. Each should predict both branch geometry and the observed cell trajectories, and its response to a spatially restricted perturbation. Randomize treatment, blind segmentation and use animals from independent clutches as biological replicates; many cells within one animal do not replace independent animals. The strongest outcome is a causal chain from molecular perturbation to altered cell behaviour to altered branch geometry, supported by rescue and by measurements showing that general developmental delay cannot explain it.

Intestinal development constructs a patterned renewing organ; intestinal homeostasis continually replaces its cells while preserving that organization. Both depend on reciprocal signalling between endoderm-derived epithelium and mesenchyme, but they solve different problems. Development expands and regionalizes the tissue, establishes architecture and produces its first mature cell types. Adult tissue homeostasis balances cell production, cell differentiation, movement and loss within an already established architecture. The mammalian small intestine provides the main comparison; its villi and crypts should not be indiscriminately attributed to the colon or to all vertebrates.

Early intestinal development begins with a broadly proliferative epithelial tube whose regional identity is established in its embryonic context. Factors including CDX2 help impose intestinal identity, while local signals distinguish the future small intestine and colon. Growth is coordinated with the formation of smooth muscle, connective tissue, the enteric nervous system and vasculature. The emergence of intestinal villi transforms a relatively simple luminal surface into an absorptive one. In mouse, epithelial Hedgehog signalling promotes underlying mesenchymal clusters, and BMP signalling helps space those clusters. In explants, increased BMP activity suppresses clusters whereas BMP inhibition produces merged clusters and abnormal villus patterns. This supports a role in pattern generation, not simply in the terminal differentiation of enterocytes.^[ref]

The mechanics and signalling must be distinguished across species. In chick, sequential smooth muscle differentiation constrains growth, generating ridges, zigzags and villi through buckling. In mouse, patterned mesenchymal clusters arise before equivalent surface deformation, so the chick sequence is not a general account of mammalian villus initiation. The common principle is reciprocal communication between layers; the ordering of mechanical and chemical patterning differs. In development, therefore, an abnormal villus pattern could arise from defective mesenchymal organization, epithelial growth or mechanical coupling, even if the final epithelial cell differentiation markers are present.

As villi emerge, proliferative cells become concentrated in intervillus regions, and intestinal crypts develop chiefly around the perinatal and postnatal transition in mouse. The fetal proliferative epithelium is consequently not simply a miniature adult crypt. Paneth cells and other components of the mature niche also appear on their own developmental schedules. Demonstrating an adult stem-cell marker in an embryonic cell would not alone establish that the embryonic lineage hierarchy or niche requirements are identical to the adult ones.

In adult small-intestinal tissue homeostasis, cycling Lgr5 positive intestinal stem cells at crypt bases generate renewed stem cells and transit-amplifying cells. Descendants differentiate into absorptive enterocytes and secretory populations including goblet cells, enteroendocrine cells, tuft cells and Paneth cells. Most differentiated descendants move toward the villus tip and are shed, whereas Paneth cells occupy the crypt base. lineage tracing from the Lgr5 locus generated persistent contributions to all epithelial lineages, providing functional evidence for self-renewal and multipotency rather than relying on marker expression alone.^[ref]

The adult niche spatially restricts developmental pathways. High local Wnt signalling and R-spondin support crypt stemness and growth, while BMP signalling restrains crypt-like programmes outside their appropriate domain. Notch signalling favours absorptive over secretory lineage allocation partly by opposing ATOH1-dependent secretory specification. Thus a single pathway can control both population maintenance and cell composition: stimulating proliferation is not sufficient if the resulting cell differentiation balance is wrong. Stromal signals are essential in vivo, and Paneth cells provide additional local support in small intestine; the colon maintains stem cells without a small-intestinal Paneth-cell arrangement. Niche dependence cannot therefore be equated with dependence on one invariant supporting cell type.

The adult organ is dynamically stable rather than cellularly static. A stem-cell clone can expand while neighbouring stem-cell clones disappear through neutral drift, with the total compartment maintained.^[ref] At the organ level, sustained excess production generates expansion or neoplasia; excess loss causes barrier failure. Development deliberately changes total cell number, surface area and proportions over time, whereas adult maintenance constrains their long-term averages. Nevertheless, adult tissue homeostasis remains responsive to feeding, microbes, immune signals and injury, and is not a completely fixed endpoint.

Experimental models expose both continuity and differences. A single sorted Lgr5 positive cell can produce a self-renewing intestinal organoid containing organized differentiated progeny in a suitable matrix and supplied growth factors. This establishes epithelial self-organization under defined conditions, not niche independence in the absence of extracellular signals: the medium replaces important niche functions.^[ref] Embryonic explants retain the mesenchyme needed to study villus patterning, while adult intestinal organoids are especially useful for stem-cell maintenance and lineage allocation. Neither alone reproduces an intact organ's circulation, innervation, immune environment and longitudinal regionalization.

Finally, injury reveals an important bridge between development and maintenance. cell fate plasticity can restore missing stem cells, so the normal adult lineage flow is not an irreversible restriction of all descendants. Committed progenitor cells can recover stem-cell function under particular injury conditions, but this does not establish that all mature villus cells routinely do so. A decisive comparison uses stage-specific lineage tracing, matched marker analysis and timed pathway perturbation, measuring architecture and functional output as well as cell proliferation. Development and adult renewal reuse molecular machinery while differing in tissue geometry, developmental competence and the direction of net population change.

The developing mammalian heart grows by a changing combination of progenitor cell recruitment and division of differentiated cardiomyocytes. Differentiation is therefore not synonymous with permanent cell-cycle exit. Premature differentiation can exhaust a progenitor cell pool, while delayed differentiation can leave many cells unable to build a functional heart. The correct balance is spatial and temporal: different cardiac populations must be supplied, expand and mature in the right order.

Early cardiac mesoderm is specified through combinations of extracellular signals and transcription factors including GATA4, NKX2-5 and TBX5. The first heart field differentiates relatively early and contributes prominently to the initial heart tube and future left ventricle. The second heart field retains proliferative progenitor cells outside the tube for longer and adds cells at its poles, with major contributions to the right ventricle and outflow tract as well as other regions. These are useful developmental populations rather than perfectly isolated compartments with one exclusive marker. The key growth mechanism is delayed recruitment: maintaining a progenitor cell reservoir allows the heart tube to lengthen after its first contractile cells have differentiated.^[ref]

FGF signalling helps support progenitor cell expansion, while BMP signalling contributes to specification and the transition toward differentiation. Their effects depend on developmental stage and location, so a global instruction to activate either pathway is inadequate. In mouse, an NKX2-5-dependent negative-feedback circuit limits Bmp2/Smad1 activity in heart-field progenitor cells. Nkx2-5 mutants initially overexpressed specification and progenitor cell programmes but subsequently failed to sustain normal second-heart-field proliferation and outflow-tract development. Reducing Smad1 activity rescued important aspects of these defects. The genetic rescue is stronger mechanistic evidence than an expression correlation: excessive specification-associated signalling can compromise the growth needed to construct the outflow tract.^[ref]

Once incorporated into the heart, embryonic cardiomyocytes assemble sarcomeres and contribute to contraction while retaining substantial proliferative capacity. cell proliferation in this differentiated population thickens chamber walls and helps produce the tissue needed for septation. Chamber myocardium and non-chamber regions follow different regulatory programmes, allowing rapid chamber expansion alongside specialized conduction and junctional territories. The goal is not simply maximum cardiomyocyte number: the arrangement, coupling and regional identity of those cells are necessary for a coordinated pump.

Signals between cardiac layers couple growth to architecture. endocardium-derived neuregulin 1 acts through myocardial ErbB receptors, including ErbB2 and ErbB4, in ventricular trabeculation. Mouse loss-of-function experiments disrupting this ligand-receptor system produce severe defects in trabecular development. The phenotype demonstrates an essential tissue interaction, but absent trabeculae must not automatically be described as a pure proliferation defect: differentiation, adhesion, cell rearrangement and survival can also contribute. Separate measurements of these processes are needed.^[ref] The epicardium and developing coronary system add further supporting signals and structural requirements as the ventricular wall grows. Proliferation must remain matched to oxygen delivery and tissue organization.

Hippo signalling provides a direct brake on myocardial expansion. When active, the pathway restricts nuclear growth-promoting activity of YAP and its cooperation with TEAD factors. Conditional disruption of Hippo components in developing mouse hearts increased cardiomyocyte proliferation and enlarged the heart. Reducing beta-catenin dosage suppressed overgrowth in the tested mutants, supporting functional interaction with Wnt signalling. This demonstrates that differentiated myocardium contains an actively regulated growth programme; its number of divisions is not merely the residue of an earlier progenitor cell state.^[ref] Conversely, unrestricted proliferation is not necessarily desirable, because chamber geometry, septation and function must mature together.

Around birth, cardiomyocytes undergo substantial changes in metabolism, sarcomere organization, electrical coupling and loading. Many mouse cardiomyocytes become binucleate or acquire polyploidy, while growth shifts increasingly toward cardiomyocyte hypertrophy. This transition is gradual and species-dependent, not a universal instantaneous switch at birth. A nucleus incorporating a nucleotide analogue may have undergone DNA replication without completing a new cell: endoreduplication and failed cytokinesis can mimic proliferation in a simple staining assay. Counts of total cardiomyocytes, nuclear number, DNA content and directly observed division are therefore needed alongside EdU and mitotic markers.

The early postnatal regeneration window illustrates the importance of developmental timing. Partial apex resection in one-day-old mice was followed by substantial myocardial restoration, and fate mapping implicated pre-existing cardiomyocytes; the reported capacity was greatly reduced by seven days of age. This is evidence that early differentiated cardiomyocytes retain regenerative potential under the tested injury conditions, rather than evidence for an indefinitely active adult cardiac stem-cell reservoir.^[ref] Injury severity and the method of measuring tissue restoration matter when comparing regenerative outcomes.

To distinguish mechanisms experimentally, combine inducible lineage tracing with stage- and lineage-specific perturbation. Deleting a regulator before heart-field specification tests a different question from deleting it after cardiomyocyte differentiation. Follow progenitor cell number, recruitment, differentiated-cell number, completed division, apoptosis and chamber structure, then test pump function. Use littermate controls, verify recombination timing and specificity, and seek pathway-specific genetic rescue. A small heart with few marker-positive cells could reflect failed specification, reduced proliferation, delayed deployment or excess death. The developmental solution is an ordered handover: expand competent progenitor cells, recruit them into differentiated tissue, permit controlled division of working myocardium, and progressively constrain division as mature structure and function are established.

The hypothesis has two distinct components: the tissue changes its material response, and that change causally affects collective cell migration. A moving tissue may generate different stresses without becoming mechanically different. Conversely, a changed viscosity or yield stress need not generate directed movement without a driving force. The experiment should distinguish force production, material response and geometry.

First obtain a time-resolved three-dimensional map of the embryo using minimally perturbing live-cell imaging. Label nuclei and membranes, register tissue motion, and measure cell speeds, directional persistence, neighbour exchanges, strain rates and the timing of morphogenesis. Track cells relative to their neighbours as well as to the microscope: bulk translation alone does not show internal rearrangement. Compare equivalent developmental stages and anatomical regions, and quantify cell proliferation, death and differentiation so that changes in tissue composition are not mistaken for migration.

Next apply a calibrated mechanical perturbation. An embedded deformable droplet with known interfacial properties can report anisotropic stresses; magnetic actuation can impose a controlled deformation and reveal recovery, viscoelasticity and a possible yield stress. A controlled force step followed by relaxation probes different timescales. Laser ablation of a loaded junction provides a complementary recoil measurement, but recoil velocity depends on both pre-existing tension and dissipation: it is not an absolute tension measurement without a mechanical model. Probe different directions because tissue response may be anisotropic.

An informative precedent combined magnetically actuated droplets and cell tracking in the extending zebrafish body axis. Posterior tissue was more fluid-like than the more mature anterior region. Perturbations of N-cadherin and contractility helped connect adhesion and rearrangements to mechanical integrity and elongation.^[ref] This motivates a specific mechanism to test in the new embryo; it does not establish that all migrating tissues undergo the same transition.

For causality, change the proposed material property locally and acutely, before migration changes. For example, use optogenetics to alter contractility in a defined region, or a reversible adhesion perturbation, with unilluminated and light-only controls. Measure the material response again rather than assuming the manipulation made the tissue stiffer. Then test whether the spatial pattern and timescale of migration change as predicted. Restore the perturbed component or reverse the manipulation to seek rescue. Mosaic interventions help distinguish changes in migrating cells from changes in their surroundings, although altered signal transduction remains a potential confounder.

Finally fit a mechanical model to measured stresses, geometry and material parameters, then predict a held-out perturbation rather than merely fitting the original flow. Replicate across embryos, randomize treatment, analyse trajectories blind to treatment, and use the embryo as the independent biological replicate. Evidence is strongest when a measured material change precedes movement, targeted intervention changes both in the predicted way, and rescue restores both without simply restoring tissue viability.

A good in-vitro model should distinguish cancer invasion, movement across a tissue boundary into surrounding material, from simple growth or movement across a flat surface. No single assay reproduces the entire sequence from a primary tumour to a distant metastasis. Choose the assay to answer a specified mechanistic question, then confirm the result in a model that retains additional biological constraints.

A scratch assay measures closure of a gap in a monolayer. It is inexpensive and permits live-cell imaging, but closure combines cell migration, spreading and cell proliferation, and the wound releases signals and damages cells. It does not by itself demonstrate invasion through a basement membrane. A porous-membrane assay can measure transit toward a stimulus; adding an extracellular barrier tests an additional requirement. Yet pore size, coating thickness, chemical gradients and the counting time can dominate the result, and endpoint cell counts hide whether treatment altered survival or actual migration.

Three-dimensional tumour spheroids or organoids embedded in a defined extracellular matrix allow individual and collective invasion to be followed over time. Quantify invasion distance, cell escape, strand architecture and leader-follower behaviour, alongside changes in spheroid size and viability. Use collagen-rich and basement-membrane-like environments to test whether a phenotype depends on matrix identity. Independently vary ligand presentation, matrix stiffness and pore dimensions where possible: increasing collagen concentration changes several of them simultaneously.

A primary study of breast tumour organoids identified invasive leader cells expressing a basal epithelial programme, including K14 and p63; reducing either component impaired collective invasion in that system. The experiment connected a defined cellular subpopulation to an invasion phenotype rather than assuming that every tumour cell was equivalent.^[ref] Its conclusion remains specific to the tested settings and does not make these markers universal requirements for invasion.

Add stromal cells, immune cells or a vessel-like boundary if the question concerns their interactions. Microfluidics can impose controlled gradients and permit live-cell imaging of entry into or exit from a channel. Include non-invasive and invasive controls, perturbation controls, rescue where feasible, and matched measurements of cell proliferation and death. Follow individual cells rather than relying solely on a final stained area. Patient-derived material should include multiple independent tumours: many fields from one culture are not independent patient replicates.

Limitations remain substantial. Culture selects cells that tolerate the medium; long-passaged lines may lose the original tumour's diversity. Matrices and added growth factors can have variable composition. Isolated cultures omit native immune surveillance, vascular perfusion, whole-organ architecture and systemic influences. Even elaborate organoids incompletely reproduce these features. Finally, invasion is only one stage: it does not establish survival in blood, colonization of a distant organ, or clinical response. Agreement across complementary assays strengthens a mechanism; no dish-based result alone proves a metastatic outcome in a person.